🇺🇸 FDA
Patent

US 11208397

Small molecule antagonists of sumo related modification of CRMP2 and uses thereof

granted A61KA61K31/4184A61P

Quick answer

US patent 11208397 (Small molecule antagonists of sumo related modification of CRMP2 and uses thereof) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/4184, A61P, A61P25/04